From the University of Texas Health Science Center at Houston, Houston, TX.
ASAIO J. 2024 Jan 1;70(1):e9-e12. doi: 10.1097/MAT.0000000000002018. Epub 2023 Aug 20.
Severe acute hypercapnia is independently associated with increased adverse effects and intensive care unit mortality in mechanically ventilated patients. During the severe acute respiratory syndrome coronavirus 2 (COVID-19) pandemic, some patients were placed on extracorporeal carbon dioxide removal support when extracorporeal membrane oxygenation (ECMO) support was at capacity or not offered. We present a patient with severe acute respiratory distress syndrome caused by COVID-19 pneumonia, who was supported with Hemolung Respiratory Assist System (ALung Technologies, Inc., LivaNova, Pittsburgh, PA) via the right subclavian vein as a bridge to lung transplantation after venovenous ECMO support. The patient survived and was discharged home.
严重急性高碳酸血症与机械通气患者不良事件增加和重症监护病房死亡率升高独立相关。在严重急性呼吸综合征冠状病毒 2（COVID-19）大流行期间，当体外膜氧合（ECMO）支持能力不足或不提供时，一些患者接受体外二氧化碳去除支持。我们介绍了 1 例由 COVID-19 肺炎引起的严重急性呼吸窘迫综合征患者，该患者在接受静脉-静脉 ECMO 支持后，通过右锁骨下静脉使用 Hemolung 呼吸辅助系统（ALung Technologies，Inc.，LivaNova，匹兹堡，PA）作为肺移植的桥接治疗存活并出院回家。
